Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial.
Saved in:
| Title: | Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial. |
|---|---|
| Authors: | Kamal A; Department of Internal Medicine, Hepatology Unit, Faculty of Medicine, Alexandria University, 1 Khartoum Square, Alexandria, 21131, Egypt. Ahmed.kamal@alexmed.edu.eg., Ghazy RM; Tropical Health Department, High Institute of Public Health, Alexandria University, Alexandria, Egypt., Sherief D; Department of Clinical Pathology, Faculty of Medicine, Kafr elsheikh University, Kafr elsheikh, Egypt., Ismail A; Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt., Ellakany WI; Department of Tropical Medicine, Faculty of Medicine, Alexandria University, Alexandria, Egypt. |
| Source: | BMC infectious diseases [BMC Infect Dis] 2023 Jan 20; Vol. 23 (1), pp. 36. Date of Electronic Publication: 2023 Jan 20. |
| Publication Type: | Randomized Controlled Trial; Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2334 |
|---|---|
| DOI: | 10.1186/s12879-023-07993-8 |
